Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment

Background:

• Pancreatic cancer exhibits poor prognosis due to therapy resistance and recurrence.
• Conventional treatments are largely ineffective, leading to rapid tumor regrowth.
• Tumor-stromal interactions protect cancer cells and enhance malignancy.

Purpose of the Study:

• To explore the role of tumor-stromal interactions in pancreatic cancer.
• To investigate novel therapeutic strategies targeting the tumor microenvironment.
• To understand mechanisms of immunosuppression in pancreatic cancer.

Main Methods:

• Identification of signaling pathways like sonic hedgehog (Shh) and connective tissue growth factor (CTGF) involved in desmoplasia.
• Investigation of myeloid-derived suppressor cells (MDSCs) and their role in immunosuppression.
• Evaluation of stroma-targeting therapies in preclinical models.

Main Results:

• Inhibition of Shh and CTGF pathways depleted desmoplasia, showing therapeutic advantages in mouse models.
• Targeting tumor stroma components demonstrated anticancer effects in vitro and in vivo.
• Suppression of stromal cell function sensitized pancreatic cancer cells to therapy.

Conclusions:

• Tumor-stromal interactions are critical in pancreatic cancer progression and therapy resistance.
• Targeting the tumor microenvironment, including stroma and immunosuppressive cells, offers a promising therapeutic strategy.
• Further research into the tumor microenvironment could improve clinical outcomes for pancreatic cancer patients.